Yarrow

Peter Fong, PhD

Chief Executive Officer

Peter is the founding CEO and board member of Yarrow Biotechnology. He is a partner and the president of RTW responsible with the management and oversight of the firm, as well as head of Asset Development and Financing (ADF). One of ADF’s primary responsibilities is the creation and incubation of RTW-founded companies.

As founding CEO and board member of RTW’s incubated companies, Peter is responsible for building the management team, pipeline, and drug development capabilities with the goal of creating the next generation of leading biotech firms capable of bringing life-saving medicines to patients. He currently also serves on the board of directors for Ji Xing Pharmaceuticals, which was founded by RTW under his leadership.

Prior to joining RTW, Peter worked at Flagship Pioneering in Cambridge as a member of the innovation team. In this role he led the creation of four Flagship companies, including Harbinger Health, and served as the founding CEO of each of them.

Peter previously worked at Genentech in Business Development, where he helped build the company’s pipeline through partnering. He led multiple transactions for Genentech, including the company’s collaboration with BioNTech to develop mRNA-based personalized cancer vaccines. He has also worked at Memorial Sloan-Kettering; Carigent Therapeutics, which he co-founded; and General Electric as a chemist.

Peter received a PhD in bioengineering from Yale University, where he subsequently was a Brown-Coxe Postdoctoral Fellow, and his BS in biochemistry from Indiana University.

Our team comprises of passionate scientists, entrepreneurs, and industry experts, united by a shared vision of pushing the boundaries of medical science.